MetLife Investment Management, LLC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 220 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 4.63 and the average weighting 0.1%.

Quarter-by-quarter ownership
MetLife Investment Management, LLC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,153,090
+22.4%
42,3230.0%0.01%
+28.6%
Q2 2023$941,687
-7.7%
42,323
-10.1%
0.01%
-12.5%
Q1 2023$1,020,164
+6.6%
47,0990.0%0.01%0.0%
Q4 2022$956,581
-20.8%
47,0990.0%0.01%
-20.0%
Q3 2022$1,207,618
+7.8%
47,0990.0%0.01%
+11.1%
Q2 2022$1,120,014
+5.6%
47,0990.0%0.01%
+28.6%
Q1 2022$1,060,669
+58.3%
47,099
+39.1%
0.01%
+16.7%
Q4 2021$670,210
+0.6%
33,8490.0%0.01%0.0%
Q3 2021$666,148
-23.1%
33,849
-14.1%
0.01%
-25.0%
Q2 2021$866,448
-7.5%
39,3840.0%0.01%
-11.1%
Q1 2021$936,945
-9.1%
39,3840.0%0.01%
-10.0%
Q4 2020$1,030,285
+36.2%
39,384
-9.3%
0.01%
+25.0%
Q3 2020$756,178
+3.5%
43,4460.0%0.01%0.0%
Q2 2020$730,762
+41.5%
43,4460.0%0.01%
+14.3%
Q1 2020$516,573
-1.7%
43,4460.0%0.01%
+40.0%
Q4 2019$525,697
-14.4%
43,4460.0%0.01%
-28.6%
Q3 2019$614,109
+26.8%
43,4460.0%0.01%
+40.0%
Q2 2019$484,423
-5.0%
43,4460.0%0.01%
-16.7%
Q1 2019$510,056
-12.1%
43,4460.0%0.01%
-14.3%
Q4 2018$580,439
-4.7%
43,4460.0%0.01%
+16.7%
Q3 2018$609,113
-10.8%
43,4460.0%0.01%
-25.0%
Q2 2018$683,000
-4.5%
43,4460.0%0.01%0.0%
Q1 2018$715,000
-8.9%
43,4460.0%0.01%
-11.1%
Q4 2017$785,00043,4460.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,003,723$95,164,0006.41%
TANAKA CAPITAL MANAGEMENT INC 65,609$780,0003.41%
S&T BANK/PA 588,620$6,999,0001.93%
Parallel Advisors, LLC 1,405,895$16,716,0001.35%
Matarin Capital Management, LLC 623,915$7,418,0001.15%
AJ WEALTH STRATEGIES, LLC 668,020$7,943,0001.08%
Capital Impact Advisors, LLC 177,300$2,108,0000.88%
Alambic Investment Management, L.P. 29,547$351,0000.85%
OXFORD FINANCIAL GROUP, LTD. LLC 332,436$3,953,0000.79%
Spark Investment Management LLC 116,400$1,383,0000.74%
View complete list of CORCEPT THERAPEUTICS INC shareholders